Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation

Blood

Volumn 80, Issue 10, 1992, Pages 2458-2462

  Bearman, S I ^a   Shuhart, M C ^a   Hinds, M S ^a   McDonald, G B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; LIVER DISEASE; MYELOID LEUKEMIA; PATIENT MONITORING; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; VEIN OCCLUSION; WEIGHT GAIN;

EID: 0026457214     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v80.10.2458.2458     Document Type: Article

References (0)